BVS vs FOX · rev $573.3M vs P/E 13, rev $16.30B
Bioventus Inc (BVS) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
BVS currently screens at market cap $495.1M. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the BVS and FOX stock pages for the full models.
Not investment advice.